These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 8669877)
1. Immunohistochemical detection of ras p21 oncoprotein in undifferentiated and well-differentiated epithelial carcinomas of the human ovary. Kuwashima Y; Shisa H; Uehara T; Kurosumi M; Kobayashi Y; Tanuma J; Shiromizu K; Matsuzawa M; Kishi K Anticancer Res; 1995; 15(6B):2847-50. PubMed ID: 8669877 [TBL] [Abstract][Full Text] [Related]
2. HOXA7 in epithelial ovarian cancer: interrelationships between differentiation and clinical features. Ota T; Gilks CB; Longacre T; Leung PC; Auersperg N Reprod Sci; 2007 Sep; 14(6):605-14. PubMed ID: 17959889 [TBL] [Abstract][Full Text] [Related]
3. Expression of survivin is associated with malignant potential in epithelial ovarian carcinoma. Takai N; Miyazaki T; Nishida M; Nasu K; Miyakawa I Int J Mol Med; 2002 Aug; 10(2):211-6. PubMed ID: 12119561 [TBL] [Abstract][Full Text] [Related]
5. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis. McCluggage WG Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic and biological determinants in undifferentiated and poorly differentiated ovarian carcinomas. Canzonieri V; Viel A; Visentin MC; Perin T; Sopracordevole F; Dall'Agnese L; Scara-Belli C; Boiocchi M; Carbone A Pathologica; 1995 Oct; 87(5):492-7. PubMed ID: 8868173 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor. Zhao C; Bratthauer GL; Barner R; Vang R Am J Surg Pathol; 2007 Sep; 31(9):1378-86. PubMed ID: 17721194 [TBL] [Abstract][Full Text] [Related]
8. Basement membrane status in undifferentiated carcinomas of the ovary. Immunohistochemical distribution of type IV collagen and laminin. Kuwashima Y; Uehara T; Kurosumi M; Kishi K; Shiromizu K; Matsuzawa M; Takayama S Eur J Gynaecol Oncol; 1995; 16(3):181-6. PubMed ID: 7664763 [TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical studies of ras oncogene product p21 in human ovarian tumors]. Yaginuma Y; Yamashita K Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1409-16. PubMed ID: 2685141 [TBL] [Abstract][Full Text] [Related]
10. EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients. Fischer-Colbrie J; Witt A; Heinzl H; Speiser P; Czerwenka K; Sevelda P; Zeillinger R Anticancer Res; 1997; 17(1B):613-9. PubMed ID: 9066588 [TBL] [Abstract][Full Text] [Related]
11. Histological classification of ovarian cancer. Kaku T; Ogawa S; Kawano Y; Ohishi Y; Kobayashi H; Hirakawa T; Nakano H Med Electron Microsc; 2003 Mar; 36(1):9-17. PubMed ID: 12658347 [TBL] [Abstract][Full Text] [Related]
12. Human ovarian tumors express gamma-glutamyl transpeptidase. Hanigan MH; Frierson HF; Brown JE; Lovell MA; Taylor PT Cancer Res; 1994 Jan; 54(1):286-90. PubMed ID: 7903206 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of topoisomerase IIalpha (Topo IIalpha) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas. Koshiyama M; Fujii H; Kinezaki M; Morita Y; Nanno H; Yoshida M Anticancer Res; 2001; 21(4B):2925-32. PubMed ID: 11712788 [TBL] [Abstract][Full Text] [Related]
14. Proliferative activity and p53 over-expression of ovarian epithelial tumors. Kuwata T; Kitagawa M; Takemura T; Hirokawa K Gen Diagn Pathol; 1995 Oct; 141(2):131-9. PubMed ID: 8548593 [TBL] [Abstract][Full Text] [Related]
15. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants. Mayr D; Hirschmann A; Löhrs U; Diebold J Gynecol Oncol; 2006 Dec; 103(3):883-7. PubMed ID: 16806438 [TBL] [Abstract][Full Text] [Related]
16. Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid. Ahmed N; Riley C; Oliva K; Stutt E; Rice GE; Quinn MA J Pathol; 2003 Oct; 201(2):229-37. PubMed ID: 14517840 [TBL] [Abstract][Full Text] [Related]
17. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters. Lin CK; Chao TK; Yu CP; Yu MH; Jin JS APMIS; 2009 Mar; 117(3):162-75. PubMed ID: 19245589 [TBL] [Abstract][Full Text] [Related]
18. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas. Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447 [TBL] [Abstract][Full Text] [Related]
19. Differential diagnosis of mesothelial and ovarian cancer cells in ascites by immunocytochemistry using Ber-EP4 and calretinin. Sato S; Okamoto S; Ito K; Konno R; Yajima A Acta Cytol; 2000; 44(3):485-8. PubMed ID: 10834020 [No Abstract] [Full Text] [Related]